Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Rb2/p130 is the dominating pocket protein in the p53–p21 DNA damage response pathway leading to senescence

Oncogene volume 28, pages 3456–3467 (2009)Cite this article

Abstract

The different pocket proteins are established as negative cell cycle regulators. With regard to the repressor functions of pocket proteins in cellular senescence, studies so far have mainly focused on pRb/p105. Here, we show that in a broad range of wild-type p53-expressing human tumor cells, and in human diploid fibroblasts, Rb2/p130 is the dominating pocket protein in replicative and in accelerated senescence. Senescent cells are arrested at the transition from late G1- to early S-phase, as indicated by the absence of S- and G2-phase cyclins A and B. Expression of cyclin A and entry into S-phase resumed after RNA interference-mediated knockdown of Rb2/p130. Activation of different upstream pathways by overexpression of either p21 or p16 converged on Rb2/p130 accumulation and induced senescence. In contrast, p53- or p21-negative cells treated with DNA-damaging agents failed to accumulate Rb2/p130 and to enter senescence. Our data suggest that Rb2/p130 is a member of the p53–p21 DNA damage signaling cascade, and represents the essential pocket protein family member needed for the induction of any type of senescence.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Araki K, Nakajima Y, Eto K, Ikeda MA . (2003). Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter. Oncogene 22: 7632–7641.

    Article  CAS  PubMed  Google Scholar 

  • Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P et al. (2003). Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 22: 4212–4222.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B et al. (2005). Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660–665.

    Article  CAS  PubMed  Google Scholar 

  • Brown JP, Wei W, Sedivy JM . (1997). Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277: 831–834.

    Article  CAS  PubMed  Google Scholar 

  • Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. (1998). Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282: 1497–1501.

    Article  CAS  PubMed  Google Scholar 

  • Chang BD, Broude EV, Dokmanovic M, Zhu H, Ruth A, Xuan Y et al. (1999). A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 59: 3761–3767.

    CAS  PubMed  Google Scholar 

  • Chang BD, Broude EV, Fang J, Kalinichenko TV, Abdryashitov R, Poole JC et al. (2000). p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 19: 2165–2170.

    Article  CAS  PubMed  Google Scholar 

  • Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al. (2005). Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725–730.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cinti C, Macaluso M, Giordano A . (2005). Tumor-specific exon 1 mutations could be the ′hit event′ predisposing Rb2/p130 gene to epigenetic silencing in lung cancer. Oncogene 24: 5821–5826.

    Article  PubMed  Google Scholar 

  • Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G et al. (1994). p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 54: 5556–5560.

    CAS  PubMed  Google Scholar 

  • Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA . (1993). Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev 7: 2392–2404.

    Article  CAS  PubMed  Google Scholar 

  • Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M et al. (2005). Tumour biology: senescence in premalignant tumours. Nature 436: 642.

    Article  CAS  PubMed  Google Scholar 

  • Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C et al. (2006). Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444: 638–642.

    Article  CAS  PubMed  Google Scholar 

  • Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363–9367.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gire V, Wynford-Thomas D . (1998). Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol Cell Biol 18: 1611–1621.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Helmbold H, Deppert W, Bohn W . (2006). Regulation of cellular senescence by Rb2/p130. Oncogene 25: 5257–5262.

    Article  CAS  PubMed  Google Scholar 

  • Jackson JG, Pereira-Smith OM . (2006). Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Mol Cell Biol 26: 2501–2510.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kapic A, Helmbold H, Reimer R, Klotzsche O, Deppert W, Bohn W . (2006). Cooperation between p53 and p130(Rb2) in induction of cellular senescence. Cell Death Differ 13: 324–334.

    Article  CAS  PubMed  Google Scholar 

  • Khanna KK . (2000). Cancer risk and the ATM gene: a continuing debate. J Natl Cancer Inst 92: 795–802.

    Article  CAS  PubMed  Google Scholar 

  • Lacy S, Whyte P . (1997). Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes. Oncogene 14: 2395–2406.

    Article  CAS  PubMed  Google Scholar 

  • Li Q, Sakurai Y, Ryu T, Azuma K, Yoshimura K, Yamanouchi Y et al. (2004). Expression of Rb2/p130 protein correlates with the degree of malignancy in gliomas. Brain Tumor Pathol 21: 121–125.

    Article  CAS  PubMed  Google Scholar 

  • Mallette FA, Ferbeyre G . (2007). The DNA damage signaling pathway connects oncogenic stress to cellular senescence. Cell Cycle 6: 1831–1836.

    Article  CAS  PubMed  Google Scholar 

  • Malumbres M, Barbacid M . (2001). To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1: 222–231.

    Article  CAS  PubMed  Google Scholar 

  • Narita M, Nunez S, Heard E, Narita M, Lin AW, Hearn SA et al. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113: 703–716.

    Article  CAS  PubMed  Google Scholar 

  • Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P . (2002). The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19: 607–614.

    Article  CAS  PubMed  Google Scholar 

  • Pardee AB . (1974). A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci USA 71: 1286–1290.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Psyrri A, DeFilippis RA, Edwards AP, Yates KE, Manuelidis L, DiMaio D . (2004). Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells. Cancer Res 64: 3079–3086.

    Article  CAS  PubMed  Google Scholar 

  • Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA et al. (2002). E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16: 245–256.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM et al. (2002). A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109: 335–346.

    Article  CAS  PubMed  Google Scholar 

  • Shan B, Chang CY, Jones D, Lee WH . (1994). The transcription factor E2F-1 mediates the autoregulation of RB gene expression. Mol Cell Biol 14: 299–309.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Susini T, Massi D, Paglierani M, Masciullo V, Scambia G, Giordano A et al. (2001). Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Hum Pathol 32: 360–367.

    Article  CAS  PubMed  Google Scholar 

  • Takahashi A, Ohtani N, Yamakoshi K, Iida S, Tahara H, Nakayama K et al. (2006). Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol 8: 1291–1297.

    Article  CAS  PubMed  Google Scholar 

  • Takahashi Y, Rayman JB, Dynlacht BD . (2000). Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14: 804–816.

    CAS  PubMed  PubMed Central  Google Scholar 

  • te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP . (2002). DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62: 1876–1883.

    CAS  PubMed  Google Scholar 

  • Tosi GM, Trimarchi C, Macaluso M, La Sala D, Ciccodicola A, Lazzi S et al. (2005). Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach. Oncogene 24: 5827–5836.

    Article  CAS  PubMed  Google Scholar 

  • Waldman T, Lengauer C, Kinzler KW, Vogelstein B . (1996). Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713–716.

    Article  CAS  PubMed  Google Scholar 

  • Zalvide J, DeCaprio JA . (1995). Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol Cell Biol 15: 5800–5810.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang B, Chen W, Roman A . (2006). The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci USA 103: 437–442.

    Article  CAS  PubMed  Google Scholar 

  • Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX et al. (2000). Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101: 79–89.

    Article  CAS  PubMed  Google Scholar 

  • Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D et al. (1993). Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7: 1111–1125.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from Deutsche Krebshilfe (German Cancer Aid) to WB. The Heinrich-Pette-Institute is financially supported by Freie und Hansestadt Hamburg and Bundesministerium für Gesundheit.

Author information

Authors and Affiliations

  1. Department of Tumorvirology, Heinrich-Pette-Institute for Experimental Virology and Immunology, University of Hamburg, Hamburg, Germany

    H Helmbold, N Kömm, W Deppert & W Bohn

Authors
  1. H Helmbold
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Kömm
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W Deppert
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W Bohn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H Helmbold.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Helmbold, H., Kömm, N., Deppert, W. et al. Rb2/p130 is the dominating pocket protein in the p53–p21 DNA damage response pathway leading to senescence. Oncogene 28, 3456–3467 (2009). https://doi.org/10.1038/onc.2009.222

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2009.222

Keywords

This article is cited by

Search

Advanced search

Quick links